4-Bromo-N-(3,4-difluorophenyl)-2-fluorobenzenesulfonamide, 97%, 100mg

Etanolamina, mínimo 99%, para síntesis, 10 l, envase de plástico.

3-Methoxy-4-(oxazol-5-yl)aniline, 95.0%, 10g

2-(4-Methoxyphenyl)propan-2-amine hydrochloride, 95.0%, 500mg

(R)-3-((Benzyloxy)carbonyl)oxazolidine-4-carboxylic acid, 98.0%, 250mg

(2R,3S)-N-Boc-3-Phenylisoserine, 95.0%, 100mg

4-Iodo-N,N-dimethylbenzenesulfonamide, 98%, 100mg

(4-((2-Methoxyphenyl)carbamoyl)phenyl)boronic acid, 98%, 5g

(4-Chloro-2-(methylthio)pyrimidin-5-yl)methanol, 95.0%, 5g

methyl 3-{1-[2-({[4-({[(hexyloxy)carbonyl]amino}methanimidoyl)phenyl]amino}methyl)-1-methyl-1H-1,3-benzodiazol-5-yl]-N-(pyridin-2-yl)formamido}propanoate, 95%, 50mg

1,2,3,4-Tetra-O-acetyl-alpha-L-fucopyranose>98.0%(HPLC)5g

7-Fluoro-5-methoxy-1H-indole, 98%, 250mg

1-Isopropyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 100mg